Stay updated with breaking news from Stephen Willard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA-compliant manufacture of intravenous Ketamine is a required component of a New Drug ApplicationIntravenous Ketamine has become widely used for treating depression and suicidality but has never...
Study May Proceed letter received from FDAIND preclinical requirements are consistent with studies already in progress to support treatment of Bipolar DepressionPotential to initiate registrational...
/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced...
Industry veteran Richard Narido joins the NRx Pharmaceuticals management teamRADNOR, Pa., Sept. 14, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company,...
RADNOR, Pa., Sept. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that Stephen Willard, J.D., Chief Executive Officer and Dr....